Cargando…

A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia

Coronavirus disease 2019 (COVID-19) has become a global pandemic since its discovery in December 2019, and as the disease continues to evolve, varying complications associated with it continue to arise. In this regard, computed tomography has played an extremely important role in the diagnosis and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakamatsu, Ikuo, Yatomi, Masakiyo, Uno, Shogo, Oishi, Yuko, Ikeuchi, Hidekazu, Hanazato, Chiharu, Sawada, Yuri, Saito, Haruka, Yamaguchi, Koichi, Kasahara, Norimitsu, Miura, Yosuke, Tsurumaki, Hiroaki, Hara, Kenichiro, Koga, Yasuhiko, Sunaga, Noriaki, Hisada, Takeshi, Hiromura, Keiju, Maeno, Toshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367777/
https://www.ncbi.nlm.nih.gov/pubmed/34422150
http://dx.doi.org/10.1016/j.radcr.2021.08.022
_version_ 1783739084835913728
author Wakamatsu, Ikuo
Yatomi, Masakiyo
Uno, Shogo
Oishi, Yuko
Ikeuchi, Hidekazu
Hanazato, Chiharu
Sawada, Yuri
Saito, Haruka
Yamaguchi, Koichi
Kasahara, Norimitsu
Miura, Yosuke
Tsurumaki, Hiroaki
Hara, Kenichiro
Koga, Yasuhiko
Sunaga, Noriaki
Hisada, Takeshi
Hiromura, Keiju
Maeno, Toshitaka
author_facet Wakamatsu, Ikuo
Yatomi, Masakiyo
Uno, Shogo
Oishi, Yuko
Ikeuchi, Hidekazu
Hanazato, Chiharu
Sawada, Yuri
Saito, Haruka
Yamaguchi, Koichi
Kasahara, Norimitsu
Miura, Yosuke
Tsurumaki, Hiroaki
Hara, Kenichiro
Koga, Yasuhiko
Sunaga, Noriaki
Hisada, Takeshi
Hiromura, Keiju
Maeno, Toshitaka
author_sort Wakamatsu, Ikuo
collection PubMed
description Coronavirus disease 2019 (COVID-19) has become a global pandemic since its discovery in December 2019, and as the disease continues to evolve, varying complications associated with it continue to arise. In this regard, computed tomography has played an extremely important role in the diagnosis and evaluation of COVID-19 pneumonia and its complications. We encountered a case of a male patient with neurofibromatosis (type I) who developed concurrent pneumothorax and pleural effusion during his recovery period from severe COVID-19 pneumonia. Pulmonary fibrosis and emphysema were also confirmed. Furthermore, an eosinophil pleural effusion appeared and was prolonged during the healing process of COVID-19. This clinical presentation suggests that fibrosis and emphysema formation due to neurofibromatosis may have caused pneumothorax and pleural effusion.
format Online
Article
Text
id pubmed-8367777
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83677772021-08-17 A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia Wakamatsu, Ikuo Yatomi, Masakiyo Uno, Shogo Oishi, Yuko Ikeuchi, Hidekazu Hanazato, Chiharu Sawada, Yuri Saito, Haruka Yamaguchi, Koichi Kasahara, Norimitsu Miura, Yosuke Tsurumaki, Hiroaki Hara, Kenichiro Koga, Yasuhiko Sunaga, Noriaki Hisada, Takeshi Hiromura, Keiju Maeno, Toshitaka Radiol Case Rep Case Report Coronavirus disease 2019 (COVID-19) has become a global pandemic since its discovery in December 2019, and as the disease continues to evolve, varying complications associated with it continue to arise. In this regard, computed tomography has played an extremely important role in the diagnosis and evaluation of COVID-19 pneumonia and its complications. We encountered a case of a male patient with neurofibromatosis (type I) who developed concurrent pneumothorax and pleural effusion during his recovery period from severe COVID-19 pneumonia. Pulmonary fibrosis and emphysema were also confirmed. Furthermore, an eosinophil pleural effusion appeared and was prolonged during the healing process of COVID-19. This clinical presentation suggests that fibrosis and emphysema formation due to neurofibromatosis may have caused pneumothorax and pleural effusion. Elsevier 2021-08-17 /pmc/articles/PMC8367777/ /pubmed/34422150 http://dx.doi.org/10.1016/j.radcr.2021.08.022 Text en © 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Wakamatsu, Ikuo
Yatomi, Masakiyo
Uno, Shogo
Oishi, Yuko
Ikeuchi, Hidekazu
Hanazato, Chiharu
Sawada, Yuri
Saito, Haruka
Yamaguchi, Koichi
Kasahara, Norimitsu
Miura, Yosuke
Tsurumaki, Hiroaki
Hara, Kenichiro
Koga, Yasuhiko
Sunaga, Noriaki
Hisada, Takeshi
Hiromura, Keiju
Maeno, Toshitaka
A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia
title A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia
title_full A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia
title_fullStr A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia
title_full_unstemmed A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia
title_short A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia
title_sort case of a patient with neurofibromatosis type i who developed pneumothorax and eosinophilic pleural effusion after suffering from covid-19 pneumonia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367777/
https://www.ncbi.nlm.nih.gov/pubmed/34422150
http://dx.doi.org/10.1016/j.radcr.2021.08.022
work_keys_str_mv AT wakamatsuikuo acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT yatomimasakiyo acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT unoshogo acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT oishiyuko acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT ikeuchihidekazu acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT hanazatochiharu acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT sawadayuri acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT saitoharuka acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT yamaguchikoichi acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT kasaharanorimitsu acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT miurayosuke acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT tsurumakihiroaki acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT harakenichiro acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT kogayasuhiko acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT sunaganoriaki acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT hisadatakeshi acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT hiromurakeiju acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT maenotoshitaka acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT wakamatsuikuo caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT yatomimasakiyo caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT unoshogo caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT oishiyuko caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT ikeuchihidekazu caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT hanazatochiharu caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT sawadayuri caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT saitoharuka caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT yamaguchikoichi caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT kasaharanorimitsu caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT miurayosuke caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT tsurumakihiroaki caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT harakenichiro caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT kogayasuhiko caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT sunaganoriaki caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT hisadatakeshi caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT hiromurakeiju caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia
AT maenotoshitaka caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia